MustGrow Biologics Corp. (CSE: MGRO) Targets Cannabis Industry with Biopesticide R&D Program Utilizing Signature, Patented Products

  • MustGrow recently announced a cannabis biopesticide research and development program, in partnership with the National Research Council Canada, focused on MustGrow’s patented natural biopesticide
  • MustGrow is also partnering with Triangle Plant Sciences (“TPS”) to offer exclusive Canadian and global access to TPS’s TP-1000 for the cannabis industry – the first product in a suite of researched hydroponic technology offerings
  • Brian Quigley, a former Altria Group senior executive with extensive regulatory prowess, was recently appointed to MustGrow’s board of directors

MustGrow Biologics Corp. (CSE: MGRO), an agricultural biotech company developing and commercializing a portfolio of natural biopesticides and biofertilizers for the cannabis industry, has a mountain of good news to share with its stakeholders. MustGrow recently issued a number of strategic press releases that illustrate the significance of the company’s signature, patented products and the potential impact they are expected to have on the cannabis industry.

In a July 11 news release, MustGrow announced that it has launched a biopesticide research and development program with the National Research Council Canada (“NRC”) (http://cnw.fm/y9WmL). The NRC and MustGrow are conducting a series of efficacy assessments of MustGrow’s patented biopesticide as a natural pre-plant, pre-pot soil treatment for soil-borne pests and diseases that affect cannabis production. MustGrow intends to seek Health Canada approval for its natural biopesticide for eventual use by Canada’s licensed cannabis producers.

MustGrow’s novel and proprietary solutions utilize organic components refined from mustard seed to provide high quality, organic pest control to growers facing challenges associated with soil-borne diseases and pests such as nematodes. The global economic impact of soil-borne nematodes is estimated at nearly $100 billion in lost crops per year. The American Phytopathological Society (http://cnw.fm/Bhd4q), an international nonprofit scientific organization dedicated to the study and control of plant diseases, estimates that plant-pathogenic nematodes are responsible for 14 percent of crop losses worldwide.

Health Canada requires mandatory testing of cannabis for a litany of pesticides and their active ingredients to ensure that pesticide-tainted cannabis is not showing up in tested products (http://cnw.fm/LtbU0). MustGrow’s pre-plant/pot soil treatment has already demonstrated control of many soil-borne diseases and pests that affect cannabis production, including Botrytis (gray mold), Fusarium, Pythium root rot, Rhizoctonia fungus, nematodes, Verticillium wilt, Phytophthora root rot and Sclerotinia.

MustGrow is also partnering with Triangle Plant Sciences (“TPS”), a division of Verdesian Life Sciences of Cary, North Carolina, to exclusively provide TPS’s TP-1000 to cannabis growers in Canada. TP-1000 is the first product in a suite of researched hydroponic technology offerings that improve nutrient utilization in support of early growth and optimal flowering, according to a news release (http://cnw.fm/G73d5). Through the partnership, MustGrow will first offer TP-1000 exclusively in Canada, followed by distribution in key registered markets around the globe.

“We are thrilled to enter into a partnership with Triangle Plant Sciences,” MustGrow Chief Operations Officer Colin Bletsky stated in the release. “The vision of TPS aligns perfectly to that of MustGrow, and we look forward to working hand-in-hand to offer the TPS suite of hydroponic products throughout Canada and, eventually, the world.”

The recent appointment of Brian Quigley to MustGrow’s board of directors is another impressive addition to the company’s growing slate of experienced industry insiders. Quigley, who brings over 20 years of regulatory expertise, brand building, marketing and operations experience with him, spent the last 16 years at Altria Group. Seven of those years were as president and CEO for U.S. Smokeless Tobacco and Nu-Mark, Altria’s innovation company.

“Brian brings extensive regulatory prowess, brand building and product innovation experience to MustGrow,” Corey Giasson, CEO of MustGrow, stated in a news release (http://cnw.fm/xxD9u). “His richly developed relationships in international food conglomerates, Big Tobacco and the cannabis community will spark powerful initiatives in all of MustGrow’s agriculture programs.”

MustGrow recently received Canadian Securities Exchange (CSE) approval for the listing of its common shares. The shares began trading on the CSE under ticker symbol ‘MGRO’ on July 10, 2019 (http://cnw.fm/TGaQ2).

For more information, visit the company’s website at www.MustGrow.ca

NOTE TO INVESTORS: The latest news and updates relating to MGRO are available in the company’s newsroom at http://cnw.fm/MGRO

About CBDWire

CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space.

To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.cbdwire.com

Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer

CBDWire (CBDW)
Denver, Colorado
cbdwire.com
303.498.7722 Office
Editor@CBDWire.com

Archives

Select A Month

CBDWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 303.498.7722